Module 8: Bone Health and Remodeling

Bone Structure and the Remodeling Cycle

Wolff’s Law – bones will develop a structure that is best able to resist the forces acting upon them

 Exercise and strength training increase bone strength

 Bone Remodeling: process in which bone tissue is broken down and then rebuilt at the same location.

 Osteoblasts: bone builders

 Osteoclasts: cells that break bone down

 Osteocytes: star-shaped cells that are the most abundant cell type in bone tissue and exchange nutrients and other factors from bone to blood and lymph

 ~10% of bone tissue is remodeled in adults each year

 Nutrients calcium, phosphorus, magnesium, fluoride, vitamin D, and vitamin K are required for bone tissues to remodel.



Bone remodeling cycle stages
  • Sequential Steps of Remodeling:

    1. Resorption: Osteoclasts mobilize to the bone surface and secrete hydrogen ions (H+\text{H}^+) to acidify the microenvironment and dissolve mineralized matrix.

    2. Reversal: Mononuclear cells prepare the site; sugars and proteins form a cement line interface between old and prospective bone; osteoblast recruitment begins.

    3. Formation: Osteoblasts lay down non-mineralized collagenous matrix termed osteoid tissue.

  1. Mineralization: Gradual deposition and dense crystallization of minerals occurring over several months.



Calcium

Most abundant mineral in the body

 >99% is stored in bone tissue

 Four functions:

1. Bone and tooth formation

 aids the mineralization process, where calcium salts crystallize into hydroxyapatite, increasing bone mineral density and strength.

2. Nerve impulse transmission

 triggers the release of neurotransmitters at synapses, facilitating ion flow between nerve cells, and without sufficient calcium, nerve function fails.

3. Muscle contraction

 when calcium levels are too low, muscles may become stiff and twitch involuntarily, leading to a condition called tetany.

4. Clotting factors

 activates clotting factors during blood vessel injury, enabling the formation of blood clots to stop bleeding.



Hormonal regulation of blood calcium homeostasis

  • Endocrine Control:

    • Parathyroid Hormone (PTH): Secreted during hypocalcemia; stimulates osteoclastic bone resorption, increases renal calcium reabsorption, and converts calcidiol into active calcitriol.

    • Calcitriol (Active Vitamin D): Operates synergistically with PTH to maximize intestinal calcium absorption and minimize urinary losses.

    • Calcitonin: Secreted by the thyroid during hypercalcemia; inhibits osteoclast-mediated bone breakdown and enhances renal calcium excretion.

Calcium Homeostasis:

  • Low Calcium: PTH and calcitriol raise calcium levels.

  • High Calcium: Calcitonin reduces calcium levels

  • Supplement Guidelines: Gastrointestinal absorption saturates at approximately 500 mg500\,\text{mg} per dose. Single massive doses impair the absorption of calcium, iron, and zinc.


CALCIUM NEEDS AND SOURCES

DRI: higher during adolescents and older age

Dietary Sources: Dairy

 Cheese 1 slice ~200mg

 1 cup nonfat milk ~300mg

 fortified orange juice, nondairy milk alternatives, cereals

 Can see content on the nutrition label


Calcium bioavailability.

Increases absorption: adequate vitamin D, stomach acid, and estrogen

Decreases absorption: oxalates, phytates, high fiber and low-fat diets, aging, decreased stomach acid, and certain health conditions


VITAMIN D: BOTH A VITAMIN AND A HORMONE

  • Types:

     D2 and D3: Found in supplements or dietary sources

     (oily fish, egg yolks, fortified milk)

     Can synthesize D3 from sunlight

  • Functions:

     Calcium absorption/homeostasis, cell growth, immune function

     Without vitamin D, < 15% of calcium is absorbed

  • Deficiency Risks:

     Rickets: Childhood disease, soft/weak bones, fracture-prone

     Osteomalacia: Adult disease, softening/weakening of bones

     Compromised bone health

  • Recommended Intake:

     RDA: 600IU/day

     National Osteoporosis Foundation: 400-800IU/da


PHOSPHORUS

Facts:

 2nd most abundant mineral in the body

 85% stored in bones

 Adequate intake in American diet

Facts:

 2nd most abundant mineral in the body

 85% stored in bones

 Adequate intake in American diet

Dietary Sources:

 Meat: Beef, chicken crab

 Dairy: Milk, yogurt, buttermilk

 Grains: Wheat, rice

 Vegetables: Broccoli, carrots

 Processed food: Cheese, cake mix, granola bars

 Beverages: Soda


MAGNESIUM

Facts:

 60% stored in the skeleton

 Deficiency linked to reduced parathyroid hormone and impaired vitamin D activation

 Supports strong bones, and a deficiency can compromise bone health

Functions:

 Bone maintenance, protein synthesis, muscle and nerve function, glucose and blood pressure control

Recommended Intake (RDA):

 Males: 400mg/day (Increases to 420mg/day after 30)

 Females: 310mg/day (Increases to 320mg/day after 30)

Dietary Sources:

 Green leafy vegetables, fish, dairy, whole grains, nuts

 Most people do not meet the RDA through diet alone


FLUORIDE

Functions:

 Tooth and bone development and maintenance

 Combats tooth decay by:

 Blocking acid formation by bacteria

 Preventing demineralization of teeth

 Enhancing remineralization of enamel

Dietary Source:

 Fluoridated drinking water


VITAMIN K

Functions:

 Fat-soluble vitamin acting as a coenzyme

 Critical for blood coagulation (required for blood clotting)

 Supports bone health by modifying osteocalcin, a protein involved in bone remodeling

Dietary Source:

 Green vegetables


BONE DEVELOPMENT ACROSS LIFE STAGES:

Infancy to Puberty: Bone growth exceeds bone loss

 Age 20: Bone growth is nearly complete

 Age 30: Peak bone mass reached

 Age 40: Bone loss exceeds bone growth (osteoclasts > osteoblasts)


BONE MINERAL DENSITY

Bone Mineral Density (BMD): Indicator of Bone Strength

 BMD measures the amount of calcified tissue in grams per cm2 of bone

 High BMD – strong bones

 Measured by Dual X-ray Absorptiometry (DEXA), with a T- score calculated

 -1.0 or above: Normal BMD

 -1.0 to -2.5: Low BMD

 -2.5 or below: Osteoporosis


OSTEOPOROSIS: A DISEASE OF BONE LOSS

Osteoporosis: Excessive bone loss over time, leading to decreased bone strength and increased risk of fractures

 Silent Disease

 Osteopenia: Lower than normal bone mass, often a precursor to osteoporosis

  • Osteopenia: Lower than normal bone mass, often a precursor to osteoporosis

Prevalence:

 10 million people with osteoporosis

 44 million with osteopenia

 Affects more women than men excessive bone loss over time

Types of Osteoporosis:

 Type 1: Postmenopausal (50-70 years), affects wrist and spine due to estrogen decline

 Type 2: Senile (>70 years), affects hip and spine (2x more common in women)


RISK FACTORS

Non-Modifiable Risk Factors:

 Age (>50), sex (female), small body frame, genetics (White or Asian)

 Low estrogen levels, endocrine disorders (e.g., hyperthyroidism)

 Family history of osteoporosis

 Medications: Glucocorticoids (stimulate bone resorption)

 Diseases: Conditions causing nutrient malabsorption (e.g., CKD, Crohn’s, anorexia), bone remodeling issues (e.g., diabetes)

Modifiable Risk Factors:

 Physical inactivity, being underweight

 Smoking, alcohol, and caffeine intake

 Poor nutrition: Low calcium, vitamin D, and protein intake


PREVENTION

Primary Prevention

 Actions to avoid disease development before it starts

Key Factors:

 50% of mineralized bone is built during puberty

 Focus on nutrition, physical activity, and fall prevention

Secondary Prevention:

 Strategies to halt or reverse osteoporosis after it has developed

 Aim: Prevent further bone loss and reduce fracture risk


POPULATIONS AT RISK

Adolescent teens

 Women with amenorrhea or female athlete triad

 Older adults

 Postmenopausal women

 Lactose-intolerant individuals

 Vegans